Your browser doesn't support javascript.
loading
Possibility of Database Research as a Means of Pharmacovigilance in Japan Based on a Comparison with Sertraline Postmarketing Surveillance.
Hirano, Yoko; Asami, Yuko; Kuribayashi, Kazuhiko; Kitazaki, Shigeru; Yamamoto, Yuji; Fujimoto, Yoko.
Affiliation
  • Hirano Y; Medical Affairs, Pfizer Essential Health, Pfizer Japan Inc., Tokyo, Japan. Electronic address: yoko.hirano@pfizer.com.
  • Asami Y; Medical Affairs, Pfizer Essential Health, Pfizer Japan Inc., Tokyo, Japan.
  • Kuribayashi K; Clinical Statistics, Pfizer Japan Inc., Tokyo, Japan.
  • Kitazaki S; MinaCare Co., Ltd., Tokyo, Japan.
  • Yamamoto Y; MinaCare Co., Ltd., Tokyo, Japan.
  • Fujimoto Y; Medical Affairs, Pfizer Essential Health, Pfizer Japan Inc., Tokyo, Japan.
Value Health Reg Issues ; 15: 1-5, 2018 May.
Article in En | MEDLINE | ID: mdl-29474173

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research / Databases, Factual / Adverse Drug Reaction Reporting Systems / Sertraline / Pharmacovigilance Type of study: Observational_studies / Screening_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Value Health Reg Issues Year: 2018 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research / Databases, Factual / Adverse Drug Reaction Reporting Systems / Sertraline / Pharmacovigilance Type of study: Observational_studies / Screening_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Value Health Reg Issues Year: 2018 Document type: Article Country of publication: United States